GlassScriptPhysician profile
Katie Powers Friday
NPI 1861759409
$2,872.17
in general payments reported to CMS, 2019-2025
35 companies · $820 in 2025
The $820 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $90.41 · 2021: $171 · 2022: $568 · 2023: $413 · 2024: $490 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.75 |
| Education | $161.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $556.66 | 2019-2025 | Veozah |
| Abbvie INC. | $382.95 | 2019-2024 | |
| Channel Medsystems, INC. | $210.03 | 2022 | |
| Pfizer INC. | $201.60 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.37 | 2022-2025 | |
| Exeltis, USA INC. | $160.43 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $135.78 | 2025 | |
| Daiichi Sankyo INC. | $83.98 | 2019-2023 | Injectafer |
| Amgen INC. | $75.43 | 2019-2024 | Prolia, Evenity |
| Millicent US INC | $68.82 | 2025 | Intrarosa, Femlyv, Femring |
| Intuitive Surgical, INC. | $64.10 | 2020-2025 | |
| Therapeuticsmd, INC. | $60.91 | 2019-2021 | |
| Organon LLC | $59.81 | 2024-2025 | Nexplanon |
| Optumhealth Care Solutions, LLC | $59.77 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Sage Therapeutics, LLC | $53.39 | 2025 | Zurzuvae |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $45.90 | 2024 | Myfembree |
| Aspira Women'S Health INC | $44.22 | 2023-2024 | Ova1 |
| Coopersurgical, INC. | $40.38 | 2024-2025 | Endosee, Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $39.50 | 2025 | Qelbree |
| Scynexis, INC. | $34.78 | 2022 | |
| Ethicon US, LLC | $29.15 | 2019 | |
| Avion Pharmaceuticals | $27.67 | 2019 | |
| Lupin INC. | $27.53 | 2019 | |
| Merck Sharp & Dohme LLC | $26.71 | 2019-2023 | Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $26.28 | 2022 | |
| Roche Diagnostics Corporation | $22.36 | 2019 | |
| Stryker Corporation | $20.55 | 2025 | Triton Canister System |
| Baxter Healthcare | $17.96 | 2021 | |
| Smith+Nephew, INC. | $17.32 | 2024 | Pico |
| Avanos Medical | $16.98 | 2021 | |
| Hologic Sales and Service, LLC | $16.57 | 2024 | Myosure Tissue Removal Device, Novasure |
| Duchesnay USA Incorporated | $14.99 | 2019 | |
| Innovation Technologies INC | $14.71 | 2025 | Irrisept |
| Meditrina | $13.99 | 2024 | |
| Amag Pharmaceuticals, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Friday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.